Skeletal Class III MalocclusionNCT07360509

Evaluation of Treatment Outcomes With Palatal Plate Versus Conventional Tooth Borne Anchorage in Class III Patients

A study testing treatment of skeletal class III by maxillary advancement using transpalatal arch and face mask and treatment of skeletal class III by maxillary advancement using palatal plate and face mask in people with Skeletal Class III Malocclusion, run by Faculty of Dental Medicine for Girls at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

evaluation of treatment outcomes with palatal plate versus conventional tooth borne anchorage in class III patients Read more about this study

Who is it for?: Ages 9 to 12 yearsHealthy volunteers can take part
Conditions the study is for: Skeletal Class III Malocclusion
What is being tested?: treatment of skeletal class III by maxillary advancement using transpalatal arch and face mask and treatment of skeletal class III by maxillary advancement using palatal plate and face mask
Type of treatment: Medical device
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 14 participants
Where: 1 siteEgypt
Study dates: 15 Aug 2023to 11 Nov 2025
Phase: Interventional
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 9 to 12 years
All sexes
Healthy volunteers accepted
Child

Who may be able to join

skeletal class III malocclusion deficient maxilla+ growing patient

Who cannot join

adult patient, cleft patient

Trial locations and contacts

1 site in 1 country.

Egypt1 site

Faculty of Dentistry , Al Azhar University, Girls Branch, Cairo
Cairo

Other trials in Egypt

About this study

evaluation of treatment outcomes with palatal plate versus conventional tooth borne anchorage in class III patients

Read the detailed description

group (A) patients were treated with transpalatal arch and facemask. group(B) patients were treated by palatal plate and facemask

Conditions: Skeletal Class III Malocclusion
Being tested: treatment of skeletal class III by maxillary advancement using transpalatal arch and face mask, treatment of skeletal class III by maxillary advancement using palatal plate and face mask

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

treatment of skeletal class III by maxillary advancement using transpalatal arch and face maskDevice
TPA group
treatment of skeletal class III by maxillary advancement using palatal plate and face maskDevice
palatal plate group

Study groups in NCT07360509
Study group	Role	What they receive
treatment of skeletal class III by maxillary advancement using transpalatal arch	Experimental	treatment of skeletal class III by maxillary advancement, using transpalatal arch and facemask Receives: Device: treatment of skeletal class III by maxillary advancement using transpalatal arch and face mask
treatment of skeletal class III by maxillary advancement by skeletal anchorage	Experimental	treatment of skeletal class III by maxillary advancement by skeletal anchorage using palatal plate and face mask Receives: Device: treatment of skeletal class III by maxillary advancement using palatal plate and face mask

What is being measured

The primary outcome is the main question the study is designed to answer.

skeletal and dental maxillary changes including SN angle, SNB angle, ANB angle
lateral cephalometry
Measured: 3-12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

15 Aug 202311 Nov 2025

First posted22 Jan 2026
Study start15 Aug 2023
Primary completion30 Sep 2025
Study completion11 Nov 2025

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Skeletal Class III MalocclusionStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Treatment
Allocation: Randomised
Intervention model: Crossover
Masking: None (open label)
Enrolment: 14 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT07360509
Sponsor's protocol ID: ORTHO-109-3-G
Status last verified: Jan 2026
First submitted: 10 Jan 2026
Last updated: 22 Jan 2026
Results posted: No
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Not yet recruiting
Clinical and Radiographic Evaluation of Low Sagittal Medial Ramus Osteotomy for Treatment of Skeletal Class II and Class III Malocclusion
Skeletal Class II Malocclusion, Skeletal Class III Malocclusion
Enrolling by invitation
Skeletal and Dentoalveolar Effects of Functional Clear Aligner Therapy in Growing Patient With Skeletal Class III Malocclusion
Skeletal Class III Malocclusion
Not yet recruiting
Effects of Invisalign Palatal Expander vs Rapid Palatal Expander With Facemask in Growing Class III Patients
Skeletal Class III Malocclusion, Transverse Maxillary Deficiency
Not yet recruiting
Comparison of Maxillary Protraction Using Tooth-borne Facemask Versus Skeletal Anchorage Chin-plate in Class III Growing Patients
Skeletal Class III Malocclusion
Enrolling by invitationPhase 1
Management of Skeletal Class III Malocclusion With Digital Bonded Reverse Twin Block in Mixed Dentition
Skeletal Class III Malocclusion

All Skeletal Class III Malocclusion trials

Study at a glance

From the registry record, last updated by the sponsor on 22 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Evaluation of Treatment Outcomes With Palatal Plate Versus Conventional Tooth Borne Anchorage in Class III Patients
ClinicalTrials.gov ID: NCT07360509
Acronym / sponsor ID: ORTHO-109-3-G
Conditions: Skeletal Class III Malocclusion
Study type: Interventional
Recruitment status: Completed
Enrolment: 14 participants (actual)
Lead sponsor: Faculty of Dental Medicine for GirlsOther government
Study start: 15 Aug 2023 (actual)
Primary completion: 30 Sep 2025 (actual)
Study completion: 11 Nov 2025 (actual)
First posted: 22 Jan 2026 (actual)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

evaluation of treatment outcomes with palatal plate versus conventional tooth borne anchorage in class III patients

Detailed description

group (A) patients were treated with transpalatal arch and facemask. group(B) patients were treated by palatal plate and facemask

Study design

Primary purpose: Treatment
Allocation: Randomised
Intervention model: Crossover
Masking: None (open label)
Number of arms: 2

Arm	Type	Receives
treatment of skeletal class III by maxillary advancement using transpalatal arch	Experimental	Device: treatment of skeletal class III by maxillary advancement using transpalatal arch and face masktreatment of skeletal class III by maxillary advancement, using transpalatal arch and facemask
treatment of skeletal class III by maxillary advancement by skeletal anchorage	Experimental	Device: treatment of skeletal class III by maxillary advancement using palatal plate and face masktreatment of skeletal class III by maxillary advancement by skeletal anchorage using palatal plate and face mask

Who may qualify

Ages: 9 to 12 years
Sex: All
Healthy volunteers: Accepted
Age groups: Child

Key inclusion criteria (1 listed)

skeletal class III malocclusion deficient maxilla+ growing patient

Key exclusion criteria (1 listed)

adult patient, cleft patient

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
treatment of skeletal class III by maxillary advancement using transpalatal arch and face maskTPA group	Device	treatment of skeletal class III by maxillary advancement using transpalatal arch
treatment of skeletal class III by maxillary advancement using palatal plate and face maskpalatal plate group	Device	treatment of skeletal class III by maxillary advancement by skeletal anchorage

Primary outcome

skeletal and dental maxillary changes including SN angle, SNB angle, ANB angle
Time frame: 3-12 months
lateral cephalometry

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 22 Jan 2026.
Treatment effects of maxillary protraction with palatal plates vs conventional tooth-borne anchorage in growing patients with Class III malocclusionLink provided by the sponsor.
Individual participant dataSharing planned: No

Related trials for Skeletal Class III Malocclusion

Not yet recruiting
Clinical and Radiographic Evaluation of Low Sagittal Medial Ramus Osteotomy for Treatment of Skeletal Class II and Class III Malocclusion
Skeletal Class II Malocclusion, Skeletal Class III Malocclusion
Enrolling by invitation
Skeletal and Dentoalveolar Effects of Functional Clear Aligner Therapy in Growing Patient With Skeletal Class III Malocclusion
Skeletal Class III Malocclusion
Not yet recruiting
Effects of Invisalign Palatal Expander vs Rapid Palatal Expander With Facemask in Growing Class III Patients
Skeletal Class III Malocclusion, Transverse Maxillary Deficiency
Not yet recruiting
Comparison of Maxillary Protraction Using Tooth-borne Facemask Versus Skeletal Anchorage Chin-plate in Class III Growing Patients
Skeletal Class III Malocclusion
Enrolling by invitationPhase 1
Management of Skeletal Class III Malocclusion With Digital Bonded Reverse Twin Block in Mixed Dentition
Skeletal Class III Malocclusion

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

The record lists no contact. Use the official record to reach the sponsor.

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

skeletal and dental maxillary changes including SN angle, SNB angle, ANB angle (time frame: 3-12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07360509.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2026.